What does TG THERAPEUTICS, INC. (TGTX) do?

TG THERAPEUTICS, INC. (TGTX) is a publicly traded company.

What sector does TGTX operate in?

TG THERAPEUTICS, INC. operates in the equity market. AlphaOS tracks cycle stage, supply-chain relationships, and investment intelligence for companies across all sectors.

Where can I find TGTX earnings analysis?

AlphaOS publishes an earnings intelligence page for TG THERAPEUTICS, INC. (TGTX) covering results, guidance context, and AI-assisted analysis. See /stocks/TGTX/earnings. Content is for research and education — not investment advice.

Intelligence coverage: 60%

Basic profile, financials, and market data are shown below. Deep research is building in the background.

TGTX

TG THERAPEUTICS, INC.

$56.19Sep 29, 2026

AI confidence 62% · prior close shown (market closed)

Investment Snapshot

Weak evidence · 1 source

Why it matters

TG THERAPEUTICS, INC. shows accelerating business momentum based on AlphaOS pipeline evidence.

Why it matters: Revenue +70% YoY in Q2 FY2026.

TrajectoryAccelerating

3 signals not yet derived from pipeline evidence

Key signals

What it means for the thesis — synthesis, not a raw event feed.

Revenue +70% YoY in Q2 FY2026

Pipeline evidence · 0d ago

TGTX's AlphaOS Signals

Upgrade to Pro for validated historical pattern analysis on TGTX.

Create free account

Free accounts see more of this; Premium sees all of it.

Latest earnings · Q2 2026

Full TGTX earnings analysis

Reported figures for TG THERAPEUTICS, INC. — research only, not investment advice.

Revenue YoY: +70.3%
EPS YoY: -70.6%

Latest Intelligence

Updated September 30, 2026

What happened recently for TG THERAPEUTICS, INC. (TGTX) — events, not interpretation.

Event: Reported Q2 2026 revenue +70% YoY.
Also: Last session September 29, 2026 at $56.19.
Source: Q2 2026 earnings

Research & analysis only — not investment advice.

Loading earnings intelligence…

TG THERAPEUTICS, INC. (TGTX)

US equity research on AlphaOS

Investment Snapshot above is the primary AlphaOS analysis for TG THERAPEUTICS, INC. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.

Key facts

Market cap:: $8.60B
Revenue:: $616.29M

TGTX earnings analysis

Research & analysis only — not investment advice. Price, charts, and filings are above.

Connected intelligence

Follow TG THERAPEUTICS, INC. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.

Connected companies and research pages from the AlphaOS knowledge graph.